Preview

Cardiovascular Therapy and Prevention

Advanced search

Analysis of the relationship between systemic inflammation and diastolic dysfunction in patients with heart failure and rheumatoid arthritis

https://doi.org/10.15829/1728-8800-2020-2382

Abstract

Aim. To study the relationship of the systemic inflammation with the morphological and functional myocardial parameters in patients with heart failure (HF) due to hypertension and coronary artery disease in combination with rheumatoid arthritis (RA).

Material and methods. The study included 57 women with NYHA class I-II HF. Patients were divided into two comparable groups: group 1 (n=31) — patients with HF and seropositive RA (Steinbrocker X-ray stage I-III); group 2 (n=26) — HF patients without RA.

Results. A comparative analysis of morphological and functional parameters did not reveal significant differences: left ventricular ejection fraction in groups 1 and 2 were 51,06±5,6% and 51,6±6,4%, respectively (p=0,7); the ratio of peak velocity blood flow in early diastole to peak velocity flow in late diastole (E/A) was 0,9±0,1 and 0,8±0,1, respectively (p=0,7). For other echocardiographic parameters, differences were also not detected (p>0,05). Nevertheless, significant regression model was created between the RA activity score (DAS28), rheumatoid factor, and E/A was created: R=0,5; R2 =0,3; F=2,6; p=0,04.

Conclusion. As a result of the study, significant direct moderate correlation of the RA activity score (DAS28) with E/A ratio was revealed in the group of patients with HF and RA. The data obtained may indicate an unfavorable prognosis of HF with an increase in RA activity.

About the Authors

A. S. Ankudinov
Irkutsk State Medical University
Russian Federation
Irkutsk


A. N. Kalyagin
Irkutsk State Medical University
Russian Federation
Irkutsk


References

1. Dickson VV, Buck H, Riegel B. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Cardiac Fail. 2011;17(5):413-9. doi:10.1016/j.cardfail.2010.11.011.

2. Serov VA, Shutov AM, Menzorov MV, et al. Epidemiology of chronic kidney disease in patients with chronic heart failure. Nephrologiya. 2010;1(14):50-5. (In Russ.) doi:10.24884/1561-6274-2010-14-1-50-55.

3. Strongin LG, Pochinka IG, Konysheva MS, Morozova EP. Glycemic control and the course of chronic heart failure in patients with type 2 diabetes. Sakharnyy Diabet. 2012;2:17- 21. (In Russ.) doi:10.14341/2072-0351-5513.

4. Kalyuta TYu, Schwartz YuG, Sokolov IM. The combination of coronary heart disease and chronic heart failure with anemic syndrome: features of the course, the effect of the correction of anemia on the prognosis. Russian Journal of Cardiology. 2013;(2):105-11. (In Russ.) doi:10.15829/1560-4071-2013-2.

5. McManus DD, Hsu G, Sung SH, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Ass. 2013;(1): e005694. doi:10.1161/JAHA.112.005694.

6. Ankudinov AS, Kalyagin AN. Analysis of the relationship of immunological factors and inflammatory markers with the course of chronic heart failure on the background of rheumatoid arthritis. Kardiologiia. 2018;58(10S):4-8. (In Russ.) doi:10.18087/cardio.2495.

7. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):363-88. doi:10.1016/j.joca.2014.01.003.

8. Brine LR. The Diabetic Heart Failure With Preserved Ejection Fraction Phenotype Is it Real and Is It Worth Targeting Therapeutically? Circulation. 2017;135(8):736-40. doi:10.1161/CIRCULATIONAHA.116.025957.

9. Mareev VYu, Fomin IV, Ageev FT, et al. Clinical recommendations OSSN — RKO — RNMOT. Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Cardiology. 2018;58(6s):8-158. (In Russ.) doi:10.18087/cardio.2475.

10. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8. doi:10.1136/ard.2010.138461.

11. Nasonov EL. Rheumatology. Clinical recommendations. M.: GEOTAR-Media, 2017. р. 464. (In Russ.) ISBN 978-5-9704-4261-6.

12. Rebrova OYu. Statistical analysis of medical data. Application of the STATISTICA application package. М.: MediaSfera, 2002. р. 312. (In Russ.) ISBN 5-89084- 013-4.

13. Prasad M, Hermann J, Sherine E, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nar Rev Cardiol. 2015;12(3):168-76. doi:10.1038/nrcardio.2014.206

14. Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic disease. Nat Rev Rheumatol. 2015;11:693-704. doi:10.1038/nrrheum.2015.112.

15. Garrido-Urbani S, Meguenani M, Montecucco F, Imhof BA. Immunological aspects of atherosclerosis. Semin Immunopathol. 2014;36(1):73-91. doi:10.1007/s00281-013-0402-8.

16. Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11:390-400. doi:10.1038/nrrheum.2015.40.

17. Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiograph. 2019;32(1):1-64. doi:10.1016/j.echo.2018.06.004.

18. Perez AV, Doehner W, Haehling S, et al. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. Int J Cardiol. 2010;141(1):39-43. doi:10.1016/j.ijcard.2008.11.146.

19. Haviv-Yadid Y, Segal Y, Dagan A, et al. Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study. Clin Rheumatol. 2019;38(11):3015-23. doi:10.1007/s10067-019-04651-w.


Review

For citations:


Ankudinov A.S., Kalyagin A.N. Analysis of the relationship between systemic inflammation and diastolic dysfunction in patients with heart failure and rheumatoid arthritis. Cardiovascular Therapy and Prevention. 2020;19(3):2382. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2382

Views: 672


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)